Drager enters $150 million Euro resuscitation market:
This article was originally published in Clinica
Executive Summary
Lubeck, Germany-based Drager Medical, a manufacturer of medical equipment for the clinical acute care and homecare sectors, has agreed to distribute Zoll Medical's resuscitation products in certain European markets. Included in the agreement are Zoll's M Series defibrillator and its new first-responder defibrillator, the ZOLL AED Plus - both of which incorporate the Burlington, Massachusetts-based company's proprietary rectilinear biphasic waveform technology. The European market for resuscitation products is worth an estimated $150m, Zoll says.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.